SuperworthXtant Medical market cap XTNT
Share price times shares outstanding: what the whole company sells for, since 2011.
- Today, Oct 23, 2026
- $39.6M
- Highest close in our data
- $337M
- Feb 2021
Xtant Medical is worth $39.6M at the close on Oct 23, 2026, at $0.28 a share.
That is down 62% over the last year and down 60% over five years.
Its highest close in our data was $337M in Feb 2021.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $39.6M | $39.6M | $104.6M | −64% |
| 2025 | $108.6M | $56.6M | $114.6M | +68% |
| 2024 | $64.5M | $50M | $154.8M | −56% |
| 2023 | $147M | $65.3M | $170.1M | +105% |
| 2022 | $71.7M | $40.6M | $74.4M | +48% |
| 2021 | $48.6M | $48.6M | $337M | −44% |
| 2020 | $86.2M | $8.4M | $93M | +291% |
| 2019 | $22M | $21M | $58.6M | −26% |
| 2018 | $29.9M | $7M | $108.7M | +187% |
| 2017 | $10.4M | $4.6M | $14.5M | +55% |
| 2016 | $6.7M | $6.1M | $38.4M | −80% |
| 2015 | $33.3M | $18.4M | $44.6M | +96% |
| 2014 | $17M | $16.9M | $50.7M | −37% |
| 2013 | $26.9M | $19.2M | $60.9M | −53% |
| 2012 | $56.7M | $49M | $136.8M | −51% |
| 2011 | $116.1M | $69.8M | $129.6M | n/a |
Against its peers
Companies in Medical - Instruments & Supplies nearest Xtant Medical's size, closest first, today.
| Company | Market cap |
|---|---|
| XTNTXtant Medical | $39.6M |
| NEPHNephros | $38.3M |
| APTAlpha Pro Tech | $56.7M |
| KEQUKewaunee Scientific | $94.9M |
| PDEXPro DEX | $199.3M |
| UTMDUtah Medical Products | $236.3M |
| INFUInfuSystem | $277.6M |
| EMBCEmbecta | $380.2M |
| Peer median | $199.3M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Xtant Medical
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.